Sensus Healthcare (NASDAQ:SRTS) Stock Price Passes Below 50-Day Moving Average of $3.72

Shares of Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $3.72 and traded as low as $3.53. Sensus Healthcare shares last traded at $3.61, with a volume of 72,070 shares.

Sensus Healthcare Trading Up 6.9 %

The firm has a 50 day moving average of $3.71 and a two-hundred day moving average of $3.08. The stock has a market capitalization of $63.27 million, a PE ratio of 128.71 and a beta of 0.92.

Sensus Healthcare (NASDAQ:SRTS - Get Free Report) last issued its quarterly earnings data on Thursday, February 8th. The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.12 by $0.14. The firm had revenue of $12.57 million for the quarter, compared to analysts' expectations of $12.10 million. Sensus Healthcare had a net margin of 1.99% and a return on equity of 1.04%. Equities research analysts forecast that Sensus Healthcare, Inc. will post 0.08 EPS for the current year.

Hedge Funds Weigh In On Sensus Healthcare

Institutional investors and hedge funds have recently modified their holdings of the company. Perritt Capital Management Inc. increased its stake in Sensus Healthcare by 5.0% during the third quarter. Perritt Capital Management Inc. now owns 105,586 shares of the company's stock worth $292,000 after acquiring an additional 5,000 shares during the last quarter. Creekmur Asset Management LLC purchased a new position in Sensus Healthcare in the fourth quarter valued at about $83,000. Finally, Sachetta LLC purchased a new position in Sensus Healthcare in the fourth quarter valued at about $247,000. Hedge funds and other institutional investors own 25.30% of the company's stock.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.